Nichols & Pratt Advisers’s Amgen AMGN Stock Holding History

Nichols & Pratt Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Hold	2,847	–	–	0.06%	67
2025 Q4	$932K	Sell	2,847 -200	-7%	-$63.4K	0.06%	69
2025 Q3	$860K	Hold	3,047	–	–	0.05%	69
2025 Q2	$851K	Sell	3,047 -37	-1%	-$10.5K	0.06%	69
2025 Q1	$961K	Sell	3,084 -225	-7%	-$66.4K	0.07%	68
2024 Q4	$862K	Sell	3,309 -835	-20%	-$248K	0.06%	71
2024 Q3	$1.34M	Sell	4,144 -100	-2%	-$32.7K	0.09%	65
2024 Q2	$1.33M	Sell	4,244 -150	-3%	-$44.1K	0.09%	64
2024 Q1	$1.25M	Sell	4,394 -700	-14%	-$205K	0.08%	64
2023 Q4	$1.47M	Hold	5,094	–	–	0.1%	62
2023 Q3	$1.37M	Buy	5,094 +557	+12%	+$139K	0.1%	63
2023 Q2	$1.01M	Sell	4,537 -38	-0.8%	-$8.82K	0.07%	68
2023 Q1	$1.11M	Hold	4,575	–	–	0.09%	64
2022 Q4	$1.2M	Buy	4,575 +600	+15%	+$161K	0.1%	62
2022 Q3	$896K	Sell	3,975 -100	-2%	-$24.2K	0.08%	67
2022 Q2	$991K	Hold	4,075	–	–	0.08%	66
2022 Q1	$986K	Hold	4,075	–	–	0.07%	69
2021 Q4	$917K	Sell	4,075 -325	-7%	-$68.6K	0.06%	71
2021 Q3	$941K	Hold	4,400	–	–	0.07%	69
2021 Q2	$1.07M	Sell	4,400 -100	-2%	-$24.6K	0.08%	68
2021 Q1	$1.12M	Hold	4,500	–	–	0.09%	67
2020 Q4	$1.03M	Hold	4,500	–	–	0.08%	66
2020 Q3	$1.14M	Hold	4,500	–	–	0.1%	60
2020 Q2	$1.06M	Hold	4,500	–	–	0.09%	60
2020 Q1	$913K	Buy	4,500 +590	+15%	+$129K	0.09%	63
2019 Q4	$943K	Sell	3,910 -1,125	-22%	-$248K	0.08%	67
2019 Q3	$974K	Sell	5,035 -2	-0%	-$384	0.08%	71
2019 Q2	$928K	Sell	5,037 -50	-1%	-$8.95K	0.08%	74
2019 Q1	$966K	Hold	5,087	–	–	0.08%	70
2018 Q4	$990K	Hold	5,087	–	–	0.09%	68
2018 Q3	$1.05M	Hold	5,087	–	–	0.09%	70
2018 Q2	$939K	Hold	5,087	–	–	0.08%	71
2018 Q1	$867K	Hold	5,087	–	–	0.08%	72
2017 Q4	$885K	Buy	5,087 +1,162	+30%	+$206K	0.08%	72
2017 Q3	$732K	Hold	3,925	–	–	0.07%	79
2017 Q2	$676K	Hold	3,925	–	–	0.06%	75
2017 Q1	$644K	Hold	3,925	–	–	0.06%	75
2016 Q4	$574K	Hold	3,925	–	–	0.05%	78
2016 Q3	$655K	Sell	3,925 -1,720	-30%	-$291K	0.06%	73
2016 Q2	$859K	Hold	5,645	–	–	0.08%	72
2016 Q1	$847K	Hold	5,645	–	–	0.08%	75
2015 Q4	$916K	Hold	5,645	–	–	0.09%	75
2015 Q3	$781K	Hold	5,645	–	–	0.08%	78
2015 Q2	$866K	Hold	5,645	–	–	0.08%	76
2015 Q1	$903K	Hold	5,645	–	–	0.08%	77
2014 Q4	$899K	Hold	5,645	–	–	0.08%	77
2014 Q3	$793K	Sell	5,645 -175	-3%	-$22.8K	0.07%	81
2014 Q2	$689K	Sell	5,820 -6,130	-51%	-$710K	0.06%	84
2014 Q1	$1.47M	Buy	11,950 +7,700	+181%	+$934K	0.13%	63
2013 Q4	$485K	Hold	4,250	–	–	0.05%	70
2013 Q3	$476K	Hold	4,250	–	–	0.05%	70
2013 Q2	$419K	Buy	+4,250	New	+$441K	0.04%	73

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Nichols & Pratt Advisers's AMGN Position: Q1 2026 in Review

Nichols & Pratt Advisers held its Amgen (AMGN) position steady in Q1 2026 at 2,847 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #67.

Nichols & Pratt Advisers first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.47M in Q1 2014. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Nichols & Pratt Advisers held 2,847 shares of Amgen worth $1M as of Q1 2026.
Nichols & Pratt Advisers left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.06% of Nichols & Pratt Advisers's portfolio in Q1 2026, its #67 holding.
Nichols & Pratt Advisers first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
Nichols & Pratt Advisers's Amgen position peaked at $1.47M in Q1 2014.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2026, filed 29 Apr 2026.